SDZNY
Price
$60.97
Change
-$0.80 (-1.30%)
Updated
Sep 4 closing price
Capitalization
26.28B
TAK
Price
$15.41
Change
+$0.12 (+0.78%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
48.27B
55 days until earnings call
Interact to see
Advertisement

SDZNY vs TAK

Header iconSDZNY vs TAK Comparison
Open Charts SDZNY vs TAKBanner chart's image
Sandoz Group AG
Price$60.97
Change-$0.80 (-1.30%)
Volume$11.73K
Capitalization26.28B
Takeda Pharmaceutical
Price$15.41
Change+$0.12 (+0.78%)
Volume$24.75K
Capitalization48.27B
SDZNY vs TAK Comparison Chart in %
Loading...
SDZNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SDZNY vs. TAK commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SDZNY is a Hold and TAK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (SDZNY: $60.97 vs. TAK: $15.29)
Brand notoriety: SDZNY and TAK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SDZNY: 55% vs. TAK: 52%
Market capitalization -- SDZNY: $26.28B vs. TAK: $48.27B
SDZNY [@Pharmaceuticals: Generic] is valued at $26.28B. TAK’s [@Pharmaceuticals: Generic] market capitalization is $48.27B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.9B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SDZNY’s FA Score shows that 0 FA rating(s) are green whileTAK’s FA Score has 1 green FA rating(s).

  • SDZNY’s FA Score: 0 green, 5 red.
  • TAK’s FA Score: 1 green, 4 red.
According to our system of comparison, SDZNY is a better buy in the long-term than TAK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SDZNY’s TA Score shows that 3 TA indicator(s) are bullish while TAK’s TA Score has 6 bullish TA indicator(s).

  • SDZNY’s TA Score: 3 bullish, 5 bearish.
  • TAK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both SDZNY and TAK are a bad buy in the short-term.

Price Growth

SDZNY (@Pharmaceuticals: Generic) experienced а -3.22% price change this week, while TAK (@Pharmaceuticals: Generic) price change was +2.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +86.08%.

Reported Earning Dates

TAK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($48.3B) has a higher market cap than SDZNY($26.3B). SDZNY has higher P/E ratio than TAK: SDZNY (117.25) vs TAK (53.12). SDZNY YTD gains are higher at: 53.110 vs. TAK (15.483). TAK has higher annual earnings (EBITDA): 1.13T vs. SDZNY (1.05B). TAK has more cash in the bank: 419B vs. SDZNY (1.39B). SDZNY has less debt than TAK: SDZNY (5.69B) vs TAK (4.51T). TAK has higher revenues than SDZNY: TAK (4.48T) vs SDZNY (10.6B).
SDZNYTAKSDZNY / TAK
Capitalization26.3B48.3B54%
EBITDA1.05B1.13T0%
Gain YTD53.11015.483343%
P/E Ratio117.2553.12221%
Revenue10.6B4.48T0%
Total Cash1.39B419B0%
Total Debt5.69B4.51T0%
FUNDAMENTALS RATINGS
TAK: Fundamental Ratings
TAK
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SDZNYTAK
RSI
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
41%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
57%
MACD
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
36%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 4 days ago
41%
Declines
ODDS (%)
Bearish Trend 4 days ago
51%
Bearish Trend 10 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
SDZNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
INTW22.261.05
+4.95%
GraniteShares 2x Long INTC Daily ETF
GSIE40.630.35
+0.87%
Goldman Sachs ActiveBeta® Intl Eq ETF
CAOS89.460.16
+0.17%
Alpha Architect Tail Risk ETF
RMMZ14.45-0.04
-0.26%
RiverNorth Managed Duration Municipal Income Fund II
SRS47.53-0.66
-1.37%
ProShares UltraShort Real Estate

SDZNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SDZNY has been loosely correlated with SDZXF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SDZNY jumps, then SDZXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDZNY
1D Price
Change %
SDZNY100%
-1.30%
SDZXF - SDZNY
44%
Loosely correlated
N/A
CPHRF - SDZNY
21%
Poorly correlated
+0.26%
TAK - SDZNY
21%
Poorly correlated
+0.92%
AVDL - SDZNY
20%
Poorly correlated
+2.25%
APNHY - SDZNY
20%
Poorly correlated
+0.68%
More